GE HEALTHCARE TECHNOLOGIES INC. GE HealthCare Technologies Inc. Stock Deutsche Boerse AG
Equities
L0T
US36266G1076
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.53 EUR | +0.75% |
|
-0.85% | +4.36% |
| Sales 2024 * | 20.16B 18.59B 27.47B | Sales 2025 * | 21.16B 19.51B 28.83B | Capitalization | 35.61B 32.84B 48.52B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.86B 1.71B 2.53B | Net income 2025 * | 2.12B 1.95B 2.89B | EV / Sales 2024 * | 2.02 x |
| Net Debt 2024 * | 5.16B 4.76B 7.03B | Net Debt 2025 * | 3.16B 2.92B 4.31B | EV / Sales 2025 * | 1.83 x |
| P/E ratio 2024 * |
19.2
x | P/E ratio 2025 * |
16.9
x | Employees | 51,000 |
| Yield 2024 * |
0.12% | Yield 2025 * |
0.22% | Free-Float | 93.06% |
More Fundamentals
* Assessed data
More news
Latest transcript on GE HealthCare Technologies Inc.
More recommendations
More press releases
More news
| 1 day | +0.75% | ||
| 1 week | -0.85% | ||
| 1 month | +1.21% | ||
| 3 months | -12.08% | ||
| 6 months | +18.90% | ||
| Current year | +4.36% |
1 week
71.51
73.91
1 month
71.5177.68
Current year
65.0086.50
1 year
58.5086.50
3 years
53.0086.50
5 years
53.0086.50
10 years
53.0086.50
| Managers | Title | Age | Since |
|---|---|---|---|
Peter Arduini
CEO | Chief Executive Officer | 59 | 22-12-13 |
James Saccaro
DFI | Director of Finance/CFO | 51 | 23-05-31 |
Jahid Khandaker
CTO | Chief Tech/Sci/R&D Officer | - | 22-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Catherine Lesjak
BRD | Director/Board Member | 65 | 22-12-13 |
Peter Arduini
CEO | Chief Executive Officer | 59 | 22-12-13 |
H. Culp
CHM | Chairman | 60 | 23-01-02 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 72.53 | +0.75% | 637 |
| 24-05-30 | 71.99 | +0.07% | 48 |
| 24-05-29 | 71.94 | -1.72% | 353 |
| 24-05-28 | 73.2 | +1.15% | 402 |
| 24-05-27 | 72.37 | -1.07% | 125 |
Delayed Quote Deutsche Boerse AG, May 31, 2024 at 08:53 am
More quotes
GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.
Calendar
2024-06-05
- Jefferies Global Healthcare Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
78
USD
Average target price
92.74
USD
Spread / Average Target
+18.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.01% | 215B | |
| +11.01% | 187B | |
| +19.20% | 143B | |
| +30.79% | 110B | |
| +1.48% | 64.68B | |
| +13.95% | 52.96B | |
| -0.16% | 49.84B | |
| -6.20% | 38.32B | |
| +19.95% | 30.75B |
- Stock Market
- Equities
- GEHC Stock
- L0T Stock
